Gilteritinib (Compound)

Synonyms:Gilteritinib, 1254053-43-4, ASP2215, ASP-2215, Xospata, UNII-66D92MGC8M, ASP 2215, 6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide, 66D92MGC8M, Gilteritinib HCl, 6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide, 2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-, 6-ethyl-3-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide, 6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide, Gilteritinib [USAN:INN], gilteritinibum, 2-Pyrazinecarboxamide, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-, C6F, Gilteritinib(ASP2215), Gilteritinib (USAN/INN), Gilteritinib (ASP2215), Gilteritinib (ASP-2215), SCHEMBL282229, GTPL8708, CHEMBL3301622, CHEBI:145372, BDBM144315, C29H44N8O3, BCP28756, EX-A2775, 3694AH, MFCD28144685, NSC787846, NSC787854, NSC788454, NSC800106, s7754, ZINC113476229, CCG-270016, CS-3885, DB12141, NSC-787846, NSC-787854, NSC-788454, NSC-800106, SB16988, NCGC00481652-01, NCGC00481652-02, AC-29030, AS-35199, BG166434, HY-12432, QC-11768, DB-108103, A14411, D10709, A901674, US8969336, 547, US8969336, 577, Q27077802, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-2-pyrazinecarboxamide, 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide, 6-Ethyl-3-[3-methoxy-4-[4-(4-methylpiperazine-1-yl)piperidino]anilino]-5-[(tetrahydro-2H-pyran-4-yl)amino]pyrazine-2-carboxamide, 6-ethyl-3-{3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide, 6-ethyl-3-{3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-[(oxan-4-yl)amino]pyrazine-2-carboxamide

Pubchem:PUBCHEM:49803313

Id:6705287d-e7be-54d3-bafd-32d861ff1b4a

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Gilteritinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Gilteritinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Gilteritinib.

Results found

Linked to

	Label	Description
	gilteritinib (b7c418f4-aef2-4f2b-9b9e-d979ee04c1a5) Collection (Entity type)	Metadatata for gilteritinib
	DCSTRUCT ID 05306 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05306; PubChem_CID:49803313, FILE=drugcentral_drug_05306.json)
	Gilteritinib bioactivity Elongation factor Tu, mitochondrial Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity Proto-oncogene tyrosine-protein kinase ROS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity GTP-binding nuclear protein Ran Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity Cytochrome c1, heme protein, mitochondrial Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity Leukocyte tyrosine kinase receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity AP2-associated protein kinase 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity Serine/threonine-protein kinase ULK3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gilteritinib bioactivity ADP/ATP translocase 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG